InduPro
InduPro develops protein-proximity platforms and therapeutics that identify and manipulate interactions between cell-surface proteins, including antibody-based modalities that bring proteins together to alter signaling. Its platforms support discovery of therapeutic targets and development of treatments for disease, with the goal of creating next-generation medicines for patients.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology
- Founded
- 2022
- Type
- Corporation Seattle business license
- Employees
- 11–50
- Registered name
- InduPro Inc Seattle business license
- Stage
- Series B
Is this your organization? Claim it
InduPro names Prakash Raman, Ph.D. CEO; Amanda J. Redig, M.D., Ph.D. serves as CMO with deep biopharma backgrounds
This page profiles InduPro's leadership, highlighting CEO Prakash Raman, Ph.D., and CMO Amanda J. Redig, M.D., Ph.D., summarizing their education and extensive biopharma and drug development experience. It emphasizes Raman’s prior roles at Ribon Therapeutics, Flagship Pioneering, and Novartis and his track record in business development, collaborations, and advancing drug candidates to clinical testing.
People
See all 4-
Amanda J. Redig Executive, Chief Medical Officer
-
Amanda Redig Executive, Chief Medical Officer
-
Prakash Raman Executive, CEO